BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26681751)

  • 21. Antisense oligonucleotides targeting hepatic angiotensinogen reduce atherosclerosis and liver steatosis in hypercholesterolemic mice.
    Ye D; Wu C; Cai L; Howatt DA; Liang CL; Katsumata Y; Mullick AE; Temel RE; Danser AHJ; Daugherty A; Lu HS
    Glob Transl Med; 2023; 2(1):. PubMed ID: 37293374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies.
    Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
    Wu H; Cheng XW; Hu L; Hao CN; Hayashi M; Takeshita K; Hamrah MS; Shi GP; Kuzuya M; Murohara T
    Atherosclerosis; 2014 Dec; 237(2):739-47. PubMed ID: 25463114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense.
    Kimura B; Mohuczy D; Tang X; Phillips MI
    Hypertension; 2001 Feb; 37(2 Pt 2):376-80. PubMed ID: 11230303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.
    Lee KC; Chan CC; Yang YY; Hsieh YC; Huang YH; Lin HC
    PLoS One; 2013; 8(10):e77817. PubMed ID: 24204981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice.
    Pöss J; Werner C; Lorenz D; Gensch C; Böhm M; Laufs U
    Basic Res Cardiol; 2010 Nov; 105(6):725-35. PubMed ID: 20857126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
    Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
    Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.
    Ravichandran K; Ozkok A; Wang Q; Mullick AE; Edelstein CL
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F349-57. PubMed ID: 25537744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
    Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA
    Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model.
    Seto SW; Krishna SM; Moran CS; Liu D; Golledge J
    Clin Sci (Lond); 2014 Jul; 127(2):123-34. PubMed ID: 24476071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
    Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L
    Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible role for nephron-derived angiotensinogen in angiotensin-II dependent hypertension.
    Ramkumar N; Stuart D; Calquin M; Wang S; Niimura F; Matsusaka T; Kohan DE
    Physiol Rep; 2016 Jan; 4(1):. PubMed ID: 26755736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity.
    Massiera F; Seydoux J; Geloen A; Quignard-Boulange A; Turban S; Saint-Marc P; Fukamizu A; Negrel R; Ailhaud G; Teboul M
    Endocrinology; 2001 Dec; 142(12):5220-5. PubMed ID: 11713218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes.
    Li J; Brasier AR
    Mol Endocrinol; 1996 Mar; 10(3):252-64. PubMed ID: 8833654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium appetite and thirst do not require angiotensinogen production in astrocytes or hepatocytes.
    Peltekian L; Gasparini S; Fazan FS; Karthik S; Iverson G; Resch JM; Geerling JC
    J Physiol; 2023 Aug; 601(16):3499-3532. PubMed ID: 37291801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for intraventricular secretion of angiotensinogen and angiotensin by the subfornical organ using transgenic mice.
    Agassandian K; Grobe JL; Liu X; Agassandian M; Thompson AP; Sigmund CD; Cassell MD
    Am J Physiol Regul Integr Comp Physiol; 2017 Jun; 312(6):R973-R981. PubMed ID: 28490451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
    Fischer R; Dechend R; Qadri F; Markovic M; Feldt S; Herse F; Park JK; Gapelyuk A; Schwarz I; Zacharzowsky UB; Plehm R; Safak E; Heuser A; Schirdewan A; Luft FC; Schunck WH; Muller DN
    Hypertension; 2008 Feb; 51(2):540-6. PubMed ID: 18158339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.
    Yiannikouris F; Karounos M; Charnigo R; English VL; Rateri DL; Daugherty A; Cassis LA
    Am J Physiol Regul Integr Comp Physiol; 2012 Jan; 302(2):R244-51. PubMed ID: 22071160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity.
    Stucchi P; Cano V; Ruiz-Gayo M; Fernández-Alfonso MS
    Br J Pharmacol; 2009 Oct; 158(3):771-8. PubMed ID: 19694726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion.
    Okubo S; Niimura F; Nishimura H; Takemoto F; Fogo A; Matsusaka T; Ichikawa I
    J Clin Invest; 1997 Mar; 99(5):855-60. PubMed ID: 9062342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.